COURAGE CAPITAL MANAGEMENT LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
COURAGE CAPITAL MANAGEMENT LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2022$829,000
+10.4%
10,0000.0%0.79%
+59.5%
Q4 2021$751,000
-35.4%
10,0000.0%0.50%
-20.3%
Q3 2021$1,162,000
-47.6%
10,0000.0%0.62%
-53.1%
Q2 2021$2,218,000
+67.8%
10,0000.0%1.33%
+37.3%
Q1 2021$1,322,000
-23.6%
10,0000.0%0.97%
-44.0%
Q4 2020$1,730,000
+55.4%
10,0000.0%1.72%
+38.7%
Q3 2020$1,113,000
+87.7%
10,0000.0%1.24%
+13.8%
Q2 2020$593,000
-11.9%
10,0000.0%1.09%
-28.2%
Q1 2020$673,000
-20.2%
10,0000.0%1.52%
-40.3%
Q4 2019$843,000
+12.7%
10,0000.0%2.55%
+112.4%
Q3 2019$748,000
-40.9%
10,000
-50.0%
1.20%
-44.2%
Q2 2019$1,265,000
+31.4%
20,0000.0%2.15%
+159.7%
Q1 2019$963,000
-28.1%
20,000
-50.0%
0.83%
-20.8%
Q4 2018$1,339,000
-89.4%
40,000
-83.3%
1.04%
-84.7%
Q3 2018$12,576,000
+46.1%
240,000
-12.7%
6.81%
+5.9%
Q2 2018$8,608,000
+43.6%
275,0000.0%6.43%
+40.6%
Q1 2018$5,995,000
+196.8%
275,000
+175.0%
4.57%
+216.5%
Q4 2017$2,020,000
+35.7%
100,000
+33.3%
1.44%
+45.1%
Q3 2017$1,489,000
-42.6%
75,000
-50.0%
1.00%
-25.3%
Q2 2017$2,595,000
-32.8%
150,000
-68.5%
1.33%
-58.0%
Q1 2017$3,861,000
-1.6%
476,717
-4.7%
3.18%
+30.7%
Q4 2016$3,925,000
-8.1%
500,0000.0%2.43%
+47.6%
Q3 2016$4,270,000500,0001.65%
Other shareholders
NOVOCURE LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders